CERVIDIL
Total Payments
$563,608
Transactions
5,496
Doctors
3,417
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1,243 | 16 | 8 |
| 2023 | $785.00 | 10 | 3 |
| 2022 | $574.74 | 11 | 11 |
| 2021 | $98.01 | 5 | 4 |
| 2020 | $1,697 | 49 | 45 |
| 2019 | $27,067 | 506 | 485 |
| 2018 | $299,848 | 2,217 | 1,695 |
| 2017 | $232,295 | 2,682 | 1,937 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $270,958 | 9 | 48.1% |
| Consulting Fee | $154,038 | 65 | 27.3% |
| Food and Beverage | $92,190 | 5,290 | 16.4% |
| Travel and Lodging | $24,459 | 104 | 4.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,614 | 9 | 3.5% |
| Education | $2,350 | 19 | 0.4% |
Payments by Type
General
$292,650
5,487 transactions
Research
$270,958
9 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Combined Use of the Controlled Release Dinoprostone Insert and Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening and Labor Induction in Term Women A Randomized Controlled Trial | Ferring Pharmaceuticals Inc. | $116,717 | 0 |
| A Trial of Cervadil dinoprostone PGE 2 insert for Outpatient Preinduction Cervical Ripening in Women at 39.0 to 41.6 weeks gestation | Ferring Pharmaceuticals Inc. | $103,427 | 0 |
| Clinical Outcomes after Formal Cervidil Training COACT | Ferring Pharmaceuticals Inc. | $50,814 | 0 |
Top Doctors Receiving Payments for CERVIDIL — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Nisha Nair | Women's Health | Fresno, CA | $155.37 | 2 |
| , MD | Reproductive Endocrinology | Redwood City, CA | $153.26 | 8 |
| , M.D | Specialist | Houston, TX | $142.83 | 8 |
| , M.D | Specialist | Houston, TX | $142.83 | 8 |
| , M.D | Obstetrics & Gynecology | Redwood City, CA | $138.82 | 7 |
| , MD | Student in an Organized Health Care Education/Training Program | Fairfax, VA | $136.64 | 8 |
| , MD | Maternal & Fetal Medicine | Orange, CA | $125.00 | 1 |
| , M.D | Maternal & Fetal Medicine | Stockton, CA | $121.32 | 7 |
| William Loftus | — | Syracuse, NY | $116.24 | 8 |
| , M.D | Obstetrics & Gynecology | East Syracuse, NY | $116.23 | 8 |
| , M.D | Obstetrics & Gynecology | Mechanicsburg, PA | $115.87 | 7 |
| , M.D | Specialist | Houston, TX | $115.59 | 6 |
| , M.D | Obstetrics & Gynecology | Park Ridge, IL | $115.12 | 7 |
| , M.D | Obstetrics & Gynecology | Rochester, NY | $114.38 | 7 |
| Gopal Reddy Gade | — | Fresno, CA | $111.62 | 5 |
| , MD | Obstetrics & Gynecology | Lodi, CA | $111.44 | 7 |
| , M.D | Obstetrics & Gynecology | Stockton, CA | $109.77 | 6 |
| , M.D | Obstetrics & Gynecology | Wauwatosa, WI | $109.16 | 6 |
| , M.D | Maternal & Fetal Medicine | Chattanooga, TN | $108.13 | 2 |
| , MD | Obstetrics & Gynecology | East Syracuse, NY | $107.04 | 8 |
| , M.D | Specialist | Houston, TX | $106.95 | 6 |
| , MD | Obstetrics & Gynecology | West Hollywood, CA | $106.40 | 4 |
| , M.D | Obstetrics & Gynecology | Winston Salem, NC | $105.91 | 2 |
| , M.D., | Obstetrics & Gynecology | Mechanicsburg, PA | $104.37 | 6 |
| , M.D | Obstetrics & Gynecology | Wauwatosa, WI | $104.23 | 6 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $563,608
- Total Doctors 3,417
- Transactions 5,496
About CERVIDIL
CERVIDIL is a drug associated with $563,608 in payments to 3,417 healthcare providers, recorded across 5,496 transactions in the CMS Open Payments database. The primary manufacturer is Ferring Pharmaceuticals Inc..
Payment data is available from 2017 to 2024. In 2024, $1,243 was paid across 16 transactions to 8 doctors.
The most common payment nature for CERVIDIL is "Unspecified" ($270,958, 48.1% of total).
CERVIDIL is associated with 3 research studies, including "Combined Use of the Controlled Release Dinoprostone Insert and Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening and Labor Induction in Term Women A Randomized Controlled Trial" ($116,717).